Phentermine hydrochloride (HCl) is indicated for the short-term management of obesity. The company expects to commence marketing this product immediately.
Arthur Bedrosian, president and CEO of Lannett, said: “This approval complements our phentermine HCI tablet 37.5mg which is the generic equivalent of Adipex-P, marketed by Gate Pharmaceuticals, a division of Teva Pharmaceutical Industries, and is an important addition to our product portfolio.”